Among these factors, MYCN amplification is one of the earliest biomarkers discovered in NB and is still considered one of the most reliable predictors of aggressive clinical behavior (Park et al., 2013; Campbell et al., 2017). The gene discussed is MYCN; the disease is neuroblastoma.